Does weight loss after laparoscopic sleeve gastrectomy contribute to reduction in blood pressure?

Diemieszczyk, Inna; Woźniewska, Paulina; Golaszewski, Piotr; Drygalski, Krzysztof; Nadolny, Klaudiusz; Ładny, Jerzy Robert; Hady, Hady Razak

doi:10.20452/pamw.16023

Cited by 8 publications

(5 citation statements)

References 30 publications

(31 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Bariatric surgery aims not only to achieve considerable, long-term weight loss but also to improve the course of obesity-related diseases such as T2DM, hypertension, dyslipidemia, obstructive sleep apnea. It also reduces the risk of cardiovascular diseases such as myocardial infarction and ischemic stroke and decreases overall mortality [75][76][77]. A meta-analysis conducted by Sutanto et al showed significant reduction in the incidence of major adverse cardiovascular events in bariatric surgery group as compared to the no-surgery group (OR = 0.49; 95% CI 0.40-0.60; p < 0.00001; I2 = 93%) [78].…”

Section: Bariatric Surgery and Nafldmentioning

confidence: 99%

Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A Review

Głuszyńska

Lemancewicz

Dzięcioł

et al. 2021

JCM

Self Cite

View full text Add to dashboard Cite

The prevalence of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) has considerably increased over the last years. NAFLD is currently the most common cause of chronic liver disease in the developing world. The diagnosis of NAFLD/NASH is often incidental, as the early-stage of disease is frequently free of symptoms. Most patients recognized with NAFLD have severe obesity and other obesity-related disease such as type 2 diabetes mellitus (T2DM), insulin-resistance, dyslipidemia and hypertension. The only proven method for NAFLD improvement and resolution is weight loss. Bariatric surgery leads to significant and long-term weight loss as well as improvement of coexisting diseases. There is a lot of evidence suggesting that metabolic/bariatric surgery is an effective method of NAFLD treatment that leads to reduction in steatosis, hepatic inflammation and fibrosis. However, there is still a need to perform long-term studies in order to determine the role of bariatric surgery as a treatment option for NAFLD and NASH. This review discusses current evidence about epidemiology, pathogenesis and treatment options for NAFLD including bariatric/metabolic surgery and its effect on improvement and resolution of NAFLD.

show abstract

Section: Bariatric Surgery and Nafldmentioning

confidence: 99%

Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A Review

Głuszyńska

Lemancewicz

Dzięcioł

et al. 2021

JCM

Self Cite

View full text Add to dashboard Cite

show abstract

“…On logistic regression, an age of < 45 years, and a short duration of T2DM from diagnosis were found to be independent predictors of complete remission [ 23 ]. A retrospective analysis of 143 obese patients diagnosed with hypertension who underwent LSG showed 23% and 63% complete and partial remissions of hypertension, respectively, at 12 months [ 24 ]. In a recent meta-analysis by Han et al [ 25 ], both LSG and LRYGB are equivalent in overall T2DM resolution.…”

Section: Discussionmentioning

confidence: 99%

Bariatric Surgery in Cebu, Philippines: Current Status and Initial Experience With Laparoscopic Sleeve Gastrectomy

Yap¹,

Eleazar²,

Roble³

et al. 2021

Cureus

View full text Add to dashboard Cite

BackgroundThe prevalence of obesity in the Philippines has increased more than three-fold over the last two decades. However, bariatric surgery has not been widely adopted yet in the country. Local data mainly on laparoscopic adjustable gastric banding (LAGB) and Roux-en-Y gastric bypass (RYGB) are limited as well. We report for the first time our experience with laparoscopic sleeve gastrectomy (LSG) and present the current local status of bariatric surgery in Cebu, Philippines. Patients and methodsThis is a retrospective study of all patients 18 years old and above who underwent LSG in a single, private, tertiary institution during the period 2009 -2019. Our primary endpoint was weight loss after LSG. Secondary endpoint was postoperative complications. ResultsThirty-three patients (mean age 40.9 ± 14.5 years) underwent LSG. Baseline weight and BMI were 112.6 ± 29 kg and 41.3 ± 8.6, respectively. The mean operative duration was 201 ± 72.9 minutes. The were no open conversions with minimal morbidity. Mean hospital stay was 3.7 ± 0.9 days. The postoperative mean weight and BMI after one year were 68.9 ± 17 kg and 26.6 ± 6, respectively. Overall, mean excess weight loss (EWL) was 61.9 ± 44.1 % at a median follow-up of 5.4 months. Significant weight loss was noted after the third month. ConclusionLSG is a safe and effective method in producing weight loss. It can be a definitive treatment option as local prevalence of obesity is increasing in the Philippines. However, access to and the practice of bariatric surgery remains limited in the country. A collaboration among private and government stakeholders is essential.

show abstract

“…Improvement in hypertension was observed in 86% of patients with 23% of patients discontinuing the therapy one year after LSG in the study conducted by Diemieszczyk et al [45] Another study by Kaya et al [46] showed a significant decrease in blood pressure, heart rate and the levels of triglycerides and low-density lipoprotein cholesterol as early as six months after LSG.…”

Section: Laparoscopic Sleeve Gastrectomymentioning

confidence: 95%

Effectiveness of laparoscopic sleeve gastrectomy and one anastomosis gastric bypass on the resolution of metabolic syndrome — a review

Łukaszewicz

Golaszewski²,

Nadolny³

et al. 2022

Medical Research Journal

View full text Add to dashboard Cite

The main cause of the development of metabolic syndrome seems to be an imbalance of calorie intake and energy expenditure. However genetic and epigenetic factors, sedentary lifestyle, poor food quality, and disturbances in gut microbiota also play a major role. There is no single effective method of treatment for metabolic syndrome. Dietary therapy and an increase in physical activity along with pharmacological treatment are not fully effective to recommend them as a therapy for metabolic syndrome. Today, modern bariatric-metabolic procedures such as laparoscopic sleeve gastrectomy or single anastomosis gastric bypass give the best chances of successful resolution of metabolic syndrome.

show abstract

Does weight loss after laparoscopic sleeve gastrectomy contribute to reduction in blood pressure?

Cited by 8 publications

References 30 publications

Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A Review

Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A Review

Bariatric Surgery in Cebu, Philippines: Current Status and Initial Experience With Laparoscopic Sleeve Gastrectomy

Effectiveness of laparoscopic sleeve gastrectomy and one anastomosis gastric bypass on the resolution of metabolic syndrome — a review

Contact Info

Product

Resources

About